Hyperglycemia and arterial stiffness: The Atherosclerosis Risk in the Communities study

Atherosclerosis

Volumn 225, Issue 1, 2012, Pages 246-251

  Rubin, Jonathan ^a   Nambi, Vijay ^b,c   Chambless, Lloyd E ^d   Steffes, Michael W ^e   Juraschek, Stephen P ^a   Coresh, Josef ^a   Sharrett, A Richey ^a   Selvin, Elizabeth ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Distensibility; Epidemiology; Hyperglycemia

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; YOUNG MODULUS;

ATHEROSCLEROSIS; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; ELASTIC MODULUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; VASCULAR STIFFNESS;

EID: 84867846163     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.003     Document Type: Article

References (33)

1. Selvin E., Coresh J., Brancati F.L. The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care 2006, 29:2415-2419.
2. Blankenhorn D.H., Kramsch D.M. Reversal of atherosis and sclerosis. The two components of atherosclerosis. Circulation 1989, 79:1-7.
3. Salomaa V., Riley W., Kark J.D., Nardo C., Folsom A.R. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC study. Atherosclerosis risk in communities study. Circulation 1995, 91:1432-1443.
4. Chen Y., Huang Y., Li X., et al. Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension. Endocrine 2009, 36:262-267.
5. Vyssoulis G., Pietri P., Vlachopoulos C., et al. Early adverse effect of abnormal glucose metabolism on arterial stiffness in drug naive hypertensive patients. Diab Vasc Dis Res 2012, 9:18-24.
6. Christen A.I., Armentano R.L., Miranda A., et al. Arterial wall structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysiological findings. Curr Diabetes Rev 2010, 6:367-377.
7. Tropeano A.I., Boutouyrie P., Katsahian S., Laloux B., Laurent S. Glucose level is a major determinant of carotid intima-media thickness in patients with hypertension and hyperglycemia. J Hypertens 2004, 22:2153-2160.
8. Schram M.T., Henry R.M., van Dijk R.A., et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn study. Hypertension 2004, 43:176-181.
9. Henry R.M.A., Kostense P.J., Spijkerman A.M.W., et al. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn study. Circulation 2003, 107:2089-2095.
10. Riley W.A., Barnes R.W., Evans G.W., Burke G.L. Ultrasonic measurement of the elastic modulus of the common carotid artery. The atherosclerosis risk in communities (ARIC) study. Stroke 1992, 23:952-956.
11. Laurent S., Cockcroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27:2588-2605.
12. The atherosclerosis risk in communities (ARIC) study: design and objectives. Am J Epidemiol 1989, 129:687-702. The ARIC investigators.
13. Riley W.A., Barnes R.W., Schey H.M. An approach to the noninvasive periodic assessment of arterial elasticity in the young. Prev Med 1984, 13:169-184.
14. Arnett D.K., Chambless L.E., Kim H., Evans G.W., Riley W. Variability in ultrasonic measurements of arterial stiffness in the atherosclerosis risk in communities study. Ultrasound Med Biol 1999, 25:175-180.
15. Sarwar N., Gao P., Seshasai S.R., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222.
16. Vlachopoulos C., Aznaouridis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010, 55:1318-1327.
17. Yang E.Y., Chambless L., Sharrett A.R., et al. Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the atherosclerosis risk in communities (ARIC) study. Stroke J Cerebr Circ 2012, 43:103-108.
18. Oxlund H., Rasmussen L.M., Andreassen T.T., Heickendorff L. Increased aortic stiffness in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989, 32:748-752.
19. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34:S62-S69.
20. Selvin E., Steffes M.W., Zhu H., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811.
21. Monnier V.M., Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981, 211:491-493.
22. Monnier V.M., Sell D.R., Genuth S. Glycation products as markers and predictors of the progression of diabetic complications. Ann N Y Acad Sci 2005, 1043:567-581.
23. Pfeifle B., Ditschuneit H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 1981, 20:155-158.
24. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984, 101:527-537.
25. McNulty M., Mahmud A., Feely J. Advanced glycation end-products and arterial stiffness in hypertension. Am J Hypertens 2007, 20:242-247.
26. Vaitkevicius P.V., Lane M., Spurgeon H., et al. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci U S A 2001, 98:1171-1175.
27. Kass D.A., Shapiro E.P., Kawaguchi M., et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001, 104:1464-1470.
28. Hartog J.W., Willemsen S., van Veldhuisen D.J., et al. Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure. Eur J Heart Fail 2011, 13:899-908.
29. Lorenz M., Markus H., Bots M., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459.
30. Rosvall M., Janzon L., Berglund G., Engstrom G., Hedblad B. Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med 2005, 257:430-437.
31. Finn A.V., Kolodgie F.D., Virmani R. Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol 2010, 30:177-181.
32. Gamble G., Zorn J., Sanders G., MacMahon S., Sharpe N. Estimation of arterial stiffness, compliance, and distensibility from M-mode ultrasound measurements of the common carotid artery. Stroke J Cerebr Circ 1994, 25:11-16.
33. Borow K.M., Newburger J.W. Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow: comparative study of indirect systolic, diastolic, and mean brachial artery pressure with simultaneous direct ascending aortic pressure measurements. Am Heart J 1982, 103:879-886.